display ongoing
results: demonstrated suggested inconclusive safety concern ongoing study
breast cancer - triple negative
es-BC - TNBC - NA - all population
atezolizumab plus SoC IMpassion-031 ... ALEXANDRA/IMpassion-030 NeoTrip Michel Angelo

Study type: